NCT00490373View on ClinicalTrials.gov

Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

April 30, 2005

Conditions
Pancreatic Cancer
Interventions
DRUG

pemetrexed

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Frankfurt

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00490373 - Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic | Biotech Hunter | Biotech Hunter